Clinicopathological characteristics and treatment outcomes of adult

Auteurs-es

  • Serkan Keskin Department of Medical Oncology, Institute of Oncology, University of Istanbul, Istanbul, Turkey
  • Mert Basaran Department of Medical Oncology, Institute of Oncology, University of Istanbul, Istanbul, Turkey
  • Isin Kilicaslan Department of Pathology, Istanbul Medical Faculty, University of Istanbul, Istanbul, Turkey
  • Murat Tunc Department of Urology, Istanbul Medical Faculty, University of Istanbul, Istanbul, Turkey
  • Sevil Bavbek Department of Medical Oncology, Institute of Oncology, University of Istanbul, Istanbul, Turkey

DOI :

https://doi.org/10.5489/cuaj.328

Résumé

Introduction: We report our experience with 8 consecutive adults treated for paratesticular rhabdomyosarcoma (RMS) at a single institution between 2000 and 2010.

Methods: After primary surgical excision, 7 patients were classified into group I according to the Intergroup Rhabdomyosarcoma Study Group (IRSG) Postsurgical Grouping Classification, and 1 patient into group IIB. Retroperitoneal node dissection was not a required staging procedure. Adjuvant chemotherapy was administered to 7 of the 8 patients. No additional radiotherapy was administered.

Results: The median age at diagnosis was 24 years (range: 18-60). Embryonal histology was the most common (75%) subtype. During follow-up, 3 patients experienced local relapse and 5 distant relapse. The median progression-free and overall survival times were 17.0 ± 9.9 months (range: 5-31) and 27.3 ± 1.3 months (range: 16-58), respectively.

Conclusion: Paratesticular RMS is an uncommon malignancy in
adults. We confirm that patients with localized paratesticular RMS may have different prognoses. Retroperitoneal lymphadenectomy can be avoided as a treatment for paratesticular RMS after radical inguinal orchiectomy.

Téléchargements

Les données relatives au téléchargement ne sont pas encore disponibles.

Bibliographies de l'auteur-e

Serkan Keskin, Department of Medical Oncology, Institute of Oncology, University of Istanbul, Istanbul, Turkey

Mert Basaran, Department of Medical Oncology, Institute of Oncology, University of Istanbul, Istanbul, Turkey

Isin Kilicaslan, Department of Pathology, Istanbul Medical Faculty, University of Istanbul, Istanbul, Turkey

Murat Tunc, Department of Urology, Istanbul Medical Faculty, University of Istanbul, Istanbul, Turkey

Sevil Bavbek, Department of Medical Oncology, Institute of Oncology, University of Istanbul, Istanbul, Turkey

Téléchargements

Publié-e

2013-02-24

Comment citer

Keskin, S., Basaran, M., Kilicaslan, I., Tunc, M., & Bavbek, S. (2013). Clinicopathological characteristics and treatment outcomes of adult. Canadian Urological Association Journal, 6(1), 42–5. https://doi.org/10.5489/cuaj.328

Numéro

Rubrique

Original Research